Cosentyx Dosing Basics
Cosentyx (secukinumab) is given as a subcutaneous injection for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and other conditions. Standard starting dose is 300 mg (two 150 mg injections) at weeks 0, 1, 2, 3, then every 4 weeks. Adjustments depend on response, weight (for kids), or condition severity.[1]
When and How Quickly Can Dosing Be Adjusted?
Doctors can adjust Cosentyx dose after initial loading doses if there's inadequate response, typically assessed at week 12 or later. Increase from 150 mg to 300 mg monthly for adults with psoriasis or psoriatic arthritis not clearing up. Changes happen at the next scheduled injection—no daily tweaks since it's not oral. For kids (6+ years, plaque psoriasis), weight-based dosing (1 mg/kg up to 300 mg) starts immediately and adjusts with growth.[1][2]
What Drives Adjustments?
- Lack of response: Upward adjustment at week 12 if PASI score (psoriasis severity) drops less than 50%.[1]
- Weight changes: Recalculate pediatric doses every 3-6 months or sooner if rapid growth.[2]
- Switching indications: Lower to 150 mg for arthritis if psoriasis controlled.[1]
No rapid intra-week changes; next dose is 4 weeks out.
Risks of Adjusting Too Soon or Late
Over-adjusting risks infections or hypersensitivity (black box warning). Under-dosing delays relief—patients report skin clearing in 4-12 weeks at full dose. Monitor via clinic visits; self-adjustment not allowed.[1][3]
Patient Options for Faster Relief
If slow response, doctors may add topicals/ phototherapy before upping Cosentyx, or switch drugs. Biosimilars like Pyzchiva (approved 2024) offer similar adjustability at lower cost.[4]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Label for Secukinumab
[3]: Drugs.com Cosentyx Side Effects
[4]: DrugPatentWatch.com - Cosentyx Patents